WO2022189292A1 - Procede de caracterisation d'un analyte present dans un echantillon gazeux contenant au moins une espece chimique parasite - Google Patents
Procede de caracterisation d'un analyte present dans un echantillon gazeux contenant au moins une espece chimique parasite Download PDFInfo
- Publication number
- WO2022189292A1 WO2022189292A1 PCT/EP2022/055555 EP2022055555W WO2022189292A1 WO 2022189292 A1 WO2022189292 A1 WO 2022189292A1 EP 2022055555 W EP2022055555 W EP 2022055555W WO 2022189292 A1 WO2022189292 A1 WO 2022189292A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- analyte
- signatures
- concentration
- species
- parasitic
- Prior art date
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 148
- 230000003071 parasitic effect Effects 0.000 title claims abstract description 58
- 239000013626 chemical specie Substances 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 36
- 238000005259 measurement Methods 0.000 claims description 120
- 238000012512 characterization method Methods 0.000 claims description 83
- 239000000243 solution Substances 0.000 claims description 48
- 230000003993 interaction Effects 0.000 claims description 47
- 239000011159 matrix material Substances 0.000 claims description 47
- 230000003287 optical effect Effects 0.000 claims description 41
- 241000894007 species Species 0.000 claims description 40
- 239000012159 carrier gas Substances 0.000 claims description 30
- 239000013598 vector Substances 0.000 claims description 28
- 238000002347 injection Methods 0.000 claims description 27
- 239000007924 injection Substances 0.000 claims description 27
- 244000045947 parasite Species 0.000 claims description 22
- 238000002336 sorption--desorption measurement Methods 0.000 claims description 17
- 239000007789 gas Substances 0.000 claims description 13
- 238000012545 processing Methods 0.000 claims description 11
- 239000012530 fluid Substances 0.000 claims description 10
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 claims description 7
- 238000000354 decomposition reaction Methods 0.000 claims description 5
- 238000005305 interferometry Methods 0.000 claims description 3
- 238000010606 normalization Methods 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 230000006870 function Effects 0.000 abstract description 32
- 238000005457 optimization Methods 0.000 abstract description 15
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000012071 phase Substances 0.000 description 81
- 230000002123 temporal effect Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 8
- 238000002310 reflectometry Methods 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000012937 correction Methods 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000012808 vapor phase Substances 0.000 description 5
- 101100460147 Sarcophaga bullata NEMS gene Proteins 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000012855 volatile organic compound Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 238000012923 label-free technique Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000001847 surface plasmon resonance imaging Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/0004—Gaseous mixtures, e.g. polluted air
- G01N33/0009—General constructional details of gas analysers, e.g. portable test equipment
- G01N33/0027—General constructional details of gas analysers, e.g. portable test equipment concerning the detector
- G01N33/0036—General constructional details of gas analysers, e.g. portable test equipment concerning the detector specially adapted to detect a particular component
- G01N33/0059—Avoiding interference of a gas with the gas to be measured
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/55—Specular reflectivity
- G01N21/552—Attenuated total reflection
- G01N21/553—Attenuated total reflection and using surface plasmons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/7703—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides
- G01N21/7746—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides the waveguide coupled to a cavity resonator
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/0004—Gaseous mixtures, e.g. polluted air
- G01N33/0009—General constructional details of gas analysers, e.g. portable test equipment
- G01N33/0011—Sample conditioning
- G01N33/0021—Sample conditioning involving the use of a carrier gas for transport to the sensor
Definitions
- the field of the invention is that of the characterization of an analyte present in a gaseous sample by means of an electronic nose.
- the gaseous sample here comprises, in addition to the analyte to be characterized, at least one chemical species capable of also interacting with the functionalized measurement surface of the electronic nose.
- the analyte present in a gaseous sample interacts by adsorption/desorption with receptors located in several distinct sensitive sites of a functionalized measurement surface. It is then a question of detecting in real time a measurement signal associated with each of the sensitive sites, representative of the adsorption/desorption interactions between the analyte and the receptors, in response to a primary signal.
- the measurement signals can be optical signals representative of a temporal variation of the local refractive index due to the interactions of the analyte with the receptors.
- the intensity of optical signals is measured in real time.
- the characterization of the analyte then amounts to determining a value or a variation of a parameter representative of the adsorption/desorption interactions of the analyte with the receptors, here representative of the temporal variation of the local refractive index for each of the sensitive sites.
- An interaction motif, or a signature which characterizes the analyte is thus obtained.
- FIGS IA and IB illustrate an example of an electronic nose of the SPR type as described in document WO2018/158458.
- This type of electronic nose 1 generally comprises a fluid supply device 2, a characterization device 3 by SPR imaging, and a processing unit (not shown).
- the characterization device 3 comprises a measurement chamber 4 intended to receive the gaseous sample, in which is located a measurement surface 5 on which is located a matrix of sensitive sites.
- the measurement surface 5 is formed of a metallic layer on which are fixed various receptors suitable for interacting with the analyte, the receptors being arranged so as to form various sensitive sites distinct from one another. These receivers are then located at the interface between the metallic layer and a dielectric medium, here a gaseous medium.
- This characterization device 3 further comprises a light source 7 of a primary optical signal and an image sensor 8.
- the light source 7 is adapted to emit the primary optical signal in the direction of the measurement surface 5, at a working angle 0 R making it possible to generate surface plasmons therein.
- the reflected part of the primary optical signal, forming an optical measurement signal, is then detected by the image sensor 8.
- the intensity of the optical measurement signal depends locally on the refractive index of the measurement surface 5, which itself depends on the surface plasmons generated and the quantity of matter located at the level of each sensitive site, this quantity of matter varying over time according to the interactions between the analyte and the receptors.
- the measurement surface 5 comprises a plurality of 6 m sensitive sites, here M distinct sensitive sites, functionalized by the presence of receptors with which the analyte to be characterized can interact by adsorption/desorption.
- the electronic nose processing unit is suitable for analyzing the "sensorgrams", that is to say the signals corresponding to the temporal evolution of the parameter representative of the adsorption/desorption interactions of the analyte with the receptors of each of the various sensitive sites 6 m , with the aim of extracting therefrom information on the kinetics of interaction (adsorption and desorption) of the analyte with the receptors.
- sensorgrams can be so-called useful signals Su m (t) corresponding to the temporal evolution of the variation A%R m (t) of the reflectivity associated with each of the sensitive sites 6 m .
- the reflectivity %R is here the ratio between the intensity of the optical measurement signal detected by the image sensor 8 over the intensity of the primary optical signal emitted by the light source 7.
- the variation in reflectivity A%R is obtained by subtracting from the temporal evolution of the reflectivity %R(t) a reference value (baseline, in English) associated with the only gas present inside the measurement chamber 4, independently of the analyte.
- the fluid supply device 2 is adapted to introduce the analyte into the measurement chamber 4 under conditions allowing the analysis of the sensorgrams and therefore the characterization of the analyte.
- the article by Brenet et al. entitled Highly-Selective Optoelectronic Nose based on Surface Plasmon Resonance Imaging for Sensing Gas Phase Volatile Organic Compounds, Anal. Chem. 2018, 90, 16, 9879-9887 describes a method for characterizing a gaseous sample using an electronic nose of the SPR imaging type. This characterization method consists in supplying the measurement chamber with a gaseous sample in such a way that the kinetics of interaction between the analyte and the receptors reaches a steady state of equilibrium.
- Figure IC illustrates an example of sensorgrams Su m (t) obtained by the electronic nose of fig.lA.
- the sensorgrams Su m (t) correspond here to the temporal evolution of the variation of the reflectivity A%R m (t) associated with each of the sensitive sites 6 m .
- the characterization method comprises several successive fluidic injection steps, namely: a first reference phase Phi, in which a carrier gas alone, without the analyte, is brought into contact with the measurement surface.
- This carrier gas is generally identical to that of the gaseous sample; a second supply phase Ph2, in which the gaseous sample, formed from the carrier gas and the analyte to be characterized, is brought into contact with the measurement surface; and a third purge phase Ph3, in which the reference gas alone is again injected into the measurement chamber, so as to dissociate the analyte from the receptors, and to evacuate it from the measurement chamber. measure.
- the initial phase Phi makes it possible to acquire the reference value ⁇ baseline), mentioned above, which is then intended to be subtracted from the measurement signals S m (t) to obtain useful signals Su m (t) ( in other words the temporal evolution of the variation in reflectivity A%R m (t) for each sensitive site of rank m).
- this phase of fluidic injection is carried out so that the sensorgrams highlight the presence of a transitory regime of assimilation followed by a stationary regime of equilibrium.
- the (steady state) equilibrium values Su m,f of the useful signals Su m (t) are extracted by the processing unit, and define the signature of the analyte.
- the object of the invention is to remedy at least in part the drawbacks of the prior art, and more particularly to propose a method for characterizing an analyte which makes it possible to limit or even eliminate the measurement noise associated with a variation in the concentration of one or more parasitic chemical species present between the initial phase Phi and the characterization phase Ph2 of fluidic injection.
- the characterization method thus makes it possible to improve the quality of characterization of the analyte.
- the object of the invention is a method for characterizing an analyte A present in a gaseous sample located in contact with a measurement surface of an electronic nose, the measurement surface comprising M sites distinct from each other, of rank m ranging from 1 to M, having receptors adapted to interact by adsorption/desorption with the analyte A and with at least one so-called parasitic chemical species P present in the gaseous sample, the method comprising the following steps: fluidic injection, to bring into contact with the measurement surface: during a first phase Phi, a carrier gas which may contain the parasitic species P with a concentration cp (n)i ; then, during a second phase Ph2, the gaseous sample containing the analyte A in concentration c A(n) and the parasite species P in concentration c P(n)f , the value c P(n)f having a difference Acp (n) not zero with the value c P(n)i ; determination of a measurement signal S (n,m
- the step of determining the estimated solution can perform the minimization of the objective function f and the maximization of the objective function g at the same time, the values of the relative concentration vector all being positive.
- the step of determining the estimated solution can be performed by an iterative algorithm, with iteration indicator i.
- the step of determining the estimated solution may include a sub-step of determining the value of the variable taking into account the value c of the variable C HAS and the value of the variable by a fixed point method.
- the step of determining the estimated solution may include a sub-step of determining the value c A +1) of the variable C A and the value of the variable k A , given the value fc of the variable k P
- the step of determining the estimated solution may include a sub-step of minimizing the objective function f to obtain a plurality of Q local solutions minimizing the objective function f, with Q>1, followed by a maximization sub-step of the objective function g.
- the minimization sub-step can provide Q local solutions formed each of the estimates of rank q going from 1 to Q, variables Q is here greater than 1: Q>1.
- the maximization sub-step may comprise the determination of Q matrices of so-called corrected signatures
- the method may comprise, following the determination of the Q corrected signature matrices Suc®, a normalization of each of the corrected signature matrices for obtain Q matrices of corrected and normalized signatures
- the method may comprise, following the determination of the Q matrices of corrected and normalized signatures S, a determination of a variance score, for each of the Q matrices the variance score being defined as the trace of the covariance matrix for each of the Q matrices having a minimum score characterizing the analyte Now in the N gas samples.
- the method may comprise, following the determination of the Q matrices of corrected signatures S a determination of a norm of each of the Q matrices followed by a matrix identification having the maximum norm.
- the matrix can be normalized, thus providing a matrix characterizing the analyte A present in the N gaseous samples.
- the electronic nose may comprise a device for measuring interactions by adsorption/desorption of the optical type with surface plasmon resonance or of the Mach-Zehnder interferometry type.
- the electronic nose may comprise a device for measuring interactions by adsorption/desorption of the resistive, piezoelectric, mechanical or acoustic type.
- the electronic nose may include a fluid supply device suitable for carrying out the fluid injection step, a measuring device suitable for carrying out the step of determining the measurement signal, a sensor for measuring and determining the the relative concentration of the parasitic chemical species, and a processing unit adapted to implement the step of determining the estimated solution.
- FIG. 1A already described, is a diagrammatic and partial view, in cross-section, of an electronic nose with SPR imaging according to an example of the prior art
- FIG. 1B already described, is a top view, schematic and partial, of a functionalized measurement surface of the electronic nose of FIG.
- FIG. 1A comprising M distinct sensitive sites
- figure IC already described, is an example of sensorgrams Su m (t) obtained by the electronic nose of fig.lA, these sensorgrams corresponding here to the temporal evolution of the variation of the reflectivity A%R m (t) associated with sensitive sites
- FIG. 2 is a schematic and partial view of an electronic nose according to one embodiment
- FIG. 3A is an example of three signatures obtained by a characterization method according to the prior art, highlighting the degradation of the characterization of the analyte due to a variation in concentration of a parasitic chemical species (here water in the vapor phase) between the initial phase Phi and the characterization phase Ph2;
- FIG. 3B illustrates the temporal evolution of the concentration cp of a parasitic chemical species, of the measurement signal S m (t) and of the useful signal Su m (t), in the case where there is no variation of the concentration c P between the initial phase Phi and the characterization phase Ph2 (left part), and in the case where there is a non-zero variation in the concentration c P between the initial phase Phi and the characterization phase Ph2 (right part);
- FIG. 4 is a flowchart of a characterization method according to a first embodiment
- FIG. 5 is a flowchart of a characterization method according to a variant of the first embodiment
- FIG. 6 is a flowchart of a characterization method according to a second embodiment;
- FIG. 7A illustrates examples of uncorrected signatures of analyte present in gaseous samples for which there has been a variation in the concentration c P of the parasitic chemical species
- Fig. 7B illustrates the analyte signatures of Fig. 7A corrected by the characterization method according to the second embodiment.
- the invention relates to the characterization of analyte A present gaseous sample to be analyzed.
- the characterization is carried out by means of an analysis system called 'electronic nose', which comprises: a measuring device; a fluid supply device fluidics; a sensor for the concentration of the parasitic chemical species P; and a processing unit.
- the measuring device comprises a functionalized measuring surface defining a plurality of sensitive sites, each sensitive site comprising receptors adapted to interact by adsorption/desorption with the analyte, and here with at least one species chemical P, different from the analyte, and therefore qualified as parasitic insofar as it induces a measurement noise on the signature of the analyte A.
- the electronic nose uses optical measurement technology by silicon interferometric technology (MZI) or by surface plasmon resonance (SFR).
- the measuring device then comprises an optical source, and at least one optical detector which can be an image sensor or a matrix of photodetectors.
- the intensity of the detected measurement signal depends on the value of the local refractive index of the sensitive site considered, which is representative of the interactions between the analyte A to be characterized (and the parasitic chemical species or species P) and the receptors.
- the measuring device can be of the resistive, piezoelectric, mechanical or acoustic type.
- the measurement signal can be an electrical signal representative of the vibration of a microbeam or equivalent.
- characterization is meant obtaining information representative of the interactions of the analyte A contained in the gaseous sample with the receptors of the sensitive sites of the electronic nose.
- the interactions in question here are events of adsorption and/or desorption of analyte A with the receptors.
- This information thus forms an interaction pattern, in other words a “signature” of the analyte, this pattern being able to be represented for example in the form of a histogram or a radar diagram.
- the signature of the analyte A is a vector of dimension M formed by the scalar representative information, these coming from the useful signal Su m (t) associated at the sensitive site considered.
- the analyte A is at least one chemical species intended to be characterized by the electronic nose, and is present in a gaseous sample. It can be, by way of illustration, bacteria, viruses, proteins, lipids, volatile organic molecules, inorganic compounds, among others.
- receptors ligands
- I ⁇ A the chemical and/or physical affinities
- Analyte A can be a single chemical species, or a set of different chemical species whose relative proportion remains constant (for example to within 5% or 10%) from one gaseous sample to another.
- the gaseous sample which contains the analyte A also contains at least one so-called parasitic chemical species P because it is distinct from the analyte A to be characterized and which can interact with the receptors. Its interaction by adsorption/desorption with the receptors impacts the measurement signal which can then comprise a useful part associated with the analyte A, and a non-useful part associated with the chemical species P in question and forming a measurement noise.
- These can be water molecules when the relative humidity of the gaseous sample is not zero, an alcohol (ethanol, butanol, etc.), hydrogen sulphide, among others.
- the concentration variation of the parasitic species P between the initial phase Phi and the characterization phase Ph2 forms a measurement noise which can degrade the quality of the characterization of the analyte A.
- the characterization method according to the invention makes it possible to limit or even eliminate this measurement noise.
- FIG. 2 is a schematic and partial view of an electronic nose 1 with SPR imaging according to one embodiment.
- the electronic nose 1 according to the invention may be similar to that described with reference to fig.lA and fig.lB, and differs essentially in that it comprises a sensor 9 for the concentration of the chemical species parasite P, located for example in the measuring chamber.
- the electronic nose may comprise the same sensor 9, or a plurality of sensors 9, adapted to measure the concentration of each parasitic species P. In the rest of the description, for the sake of clarity, it is considered that there is only one parasitic chemical species P.
- the electronic nose 1 is based, in this example, on SPR technology and has in this example the characteristics of the so-called Kretschmann configuration, known to those skilled in the art, without the invention however being limited to this configuration.
- other measurement techniques can be used, such as measurements the resonance frequency of a functionalized MEMS or NEMS type microresonator.
- the electronic nose 1 can also be based on an optical measurement by Mach-Zehnder type interferometry, for example in photonic technology on silicon, as described in the patent application FR2011842 filed on 11/18/2020.
- the electronic nose 1 comprises M sensitive sites 6 m , with m ranging from 1 to M, distinct from each other and located in a measurement chamber 4 intended to receive the gaseous sample to be analyzed, these sensitive sites 6 m being formed each of the receptors capable of interacting with the analyte A to be characterized (cf. fig.lB) and here with the parasite species P.
- the sensitive sites 6 m are distinct from each other, in the sense that they comprise different receptors, in terms of chemical and/or physical affinity with respect to the analyte A to be characterized, and are therefore intended to provide information on the interaction that differs from one sensitive site 6 m to another.
- the 6 m sensitive sites are distinct zones of a surface measuring 5, and can be joined or spaced from each other.
- the electronic nose 1 can also comprise several identical sensitive sites, for the purpose, for example, of detecting a possible measurement drift and/or of allowing the identification of a defective sensitive site.
- the electronic nose comprises a measuring device 3, here of the SPR imaging type, making it possible to quantify the interactions of the chemical species with the receptors, for each sensitive site 6 m , here by measuring in real time the intensity of a optical measurement signal coming from the sensitive site 6 m considered, this optical signal here being a reflected part of a primary optical signal emitted by a light source 7.
- the intensity of the optical measurement signal detected by the optical sensor 8 is directly correlated in particular to the adsorption/desorption interactions of the chemical species with the receptors.
- the measurement signal can be an electrical signal representative of the vibration of a microbeam or equivalent.
- the measurement device 3 is adapted to acquire in real time the optical measurement signal S m (t) originating from all of the sensitive sites 6 m .
- the optical measurement signals S m (t) coming from the sensitive sites 6 m in response to the primary optical signal are detected together and in real time, in the form of an image acquired by the same optical sensor 8.
- the optical measuring device 3 comprises a light source 7 adapted to transmit a primary optical signal in the direction of the sensitive sites 6 m , and to generate surface plasmons at the level of the measuring support 5.
- the light source 7 may be formed of a light-emitting diode, the emission spectrum of which has an emission peak centered on a central wavelength ⁇ c .
- Different optical elements can be arranged between the light source 7 and the measurement support 5.
- the optical measuring device 3 further comprises an optical sensor 8, and here an image sensor, that is to say a matrix optical sensor adapted to collect or detect an image of the optical signal coming from the sensitive sites in response to the primary optical signal.
- the image sensor 8 is a matrix photodetector, for example a CMOS or CCD sensor. It therefore comprises a matrix of pixels whose spatial resolution is such that, preferably, several pixels acquire the optical measurement signal coming from the same sensitive site 6 m .
- the processing unit allows the implementation of the processing operations described below within the framework of the characterization method. It may comprise at least one microprocessor and at least one memory. It is connected to the optical measuring device 3, and more precisely to the image sensor 8. It comprises a programmable processor capable of executing instructions recorded on an information recording medium. It also comprises at least one memory containing the instructions necessary for implementing the characterization method. The memory is also suitable for storing the information calculated at each measurement instant.
- the processing unit is in particular suitable for storing and processing a plurality of so-called elementary images acquired at a given sampling frequency f e , over a measurement period D ⁇ , in order to determine a measurement signal S m (ti), at the current instant t i , associated with the sensitive site 6 m .
- the measurement signal S m (ti) corresponds, at a measurement time t, to the average of the intensity of the optical signal reflected and detected by the image sensor 8 on the pixels associated with the sensitive site 6 m .
- the average of the optical intensity detected on the pixels can be carried out for one or more images of the sensitive site 6 m , as described in detail later.
- the fluid supply device 2 is adapted to supply the measurement chamber 4 with a carrier gas alone (ie without the analyte A) during the initial phase Phi, and with a gaseous sample formed from the carrier gas and the analytes during the Ph2 characterization phase.
- the gaseous sample differs from the carrier gas essentially in that it comprises the analyte A to be characterized: the parasitic species P is present in the gaseous sample, and may or may not also be present in the carrier gas.
- One or more additional gases may be present, but are odorless in the sense that they substantially induce no response from the electronic nose 1.
- An example of additional gas present in the second gas sample may be vapor phase diluent.
- the analyte A can thus be stored in a liquid diluent contained in a reservoir 10.
- the phase diluent vapor and analyte A are added to the carrier gas (eg moist air) to form the sample gas.
- the carrier gas eg moist air
- the fluid supply device 2 may comprise an inlet 11 of carrier gas, and a reservoir 10 of analyte A.
- the reservoir 10 contains a diluent in which is located the analyte A. It comprises several fluidic lines which connect the inlet 11 of the carrier gas and the reservoir 10 on the one hand, to the inlet of the measurement chamber 4 on the other hand, and comprises valves and possibly mass flow regulators.
- the electronic nose further comprises a sensor 9 of the concentration cp of the parasitic species P, for example here a relative humidity sensor.
- the concentration variation c P of the parasite species P present in the measurement chamber during the fluid injection step forms a measurement noise which degrades the characterization quality.
- This measurement noise is a noise linked to a non-zero difference in concentration cp within the measurement chamber between the initial phase Phi and the characterization phase Ph2. It is a measurement noise insofar as it results from a temporal variation of a parameter which characterizes the environment inside the measurement chamber and should normally remain stationary over time.
- This problem of measurement noise linked to Acp is particularly important when the characterization method is carried out from useful signals Su m (t), that is to say that it comprises a step of subtracting the reference value S m ,i (baseline) to the corresponding measurement signal S m (t).
- the purpose of this step consists in ruling out from the characterization of the analyte A the effect associated with their environment and in particular the effect of the carrier gas.
- this reference value S mi is representative of the carrier gas during the initial phase Phi, but is no longer necessarily representative of the carrier gas during the characterization phase Ph2 since the physical properties of this carrier gas in the measurement chamber may have changed (variation in the concentration cp of the parasitic species P).
- FIG. 3A illustrates three interaction patterns, or signatures, reflecting the characterization of different gaseous samples, this characterization being carried out by a characterization method according to an example of the prior art.
- These signatures M1, M2 and M3 are here representations in the form of a radar diagram of the (stationary) equilibrium values Su m,f determined from the sensorgrams Su m (t) in the steady state of equilibrium Ph2 .2 (see fig.lC). They make it possible to highlight the effect of the variation in concentration cp between the phases of fluidic injection Phi and Ph2, here a relative concentration Acp, on the characterization of the analyte A.
- the carrier gas is identical for the three tests and corresponds to humid air having an initial relative humidity cp j of approximately 12%.
- a first signature M1 corresponds to a gaseous sample formed from humid air with a relative humidity cp ,f equal to approximately 50% and whose analyte A is butanol molecules.
- the implementation of the characterization process thus presents a relatively large variation in the relative humidity in the measurement chamber, which here goes from cp j equal to approximately 12% during the initial phase Phi, to cp ,f equal to 50 % approximately during the characterization phase.
- the reference value S mi is determined for the carrier gas (humid air at c P i of 12%) and the equilibrium value is determined for the gaseous sample (humid air at c P,f of 50% with the analyte A) by subtracting this reference value S mi .
- This relative concentration Ac P thus forms a measurement noise whose effect it is important to limit so that the signature M1 is effectively representative only of the butanol molecules.
- a second signature M2 corresponds to a gaseous sample formed from humid air with a relative humidity cp ,f substantially equal to cp j (ie 12%), and whose analyte A is also butanol molecules.
- the implementation of the characterization method makes it possible, by subtracting the reference value S m,i associated with the carrier gas (humid air at cp j ), and insofar as the variation in relative humidity Acp is zero, to rule out the effect of the gaseous environment to thus characterize the interactions of analyte A with the receptors alone.
- the signature M2 is representative of analyte A alone since there is no measurement noise associated with a variation in relative humidity Acp.
- the signature M1 is not superimposed on the signature M2, clearly reflecting the presence of the measurement noise associated with Ac P in the case of M1. It is therefore important to be able to correct the signature M1 to tend towards the signature M2, which is the only representative of the analyte, even though there is a difference in relative humidity Acp in the measurement chamber between the initial phase Phi and the characterization phase Ph2.
- the third signature M3 corresponds to a gaseous sample formed solely of humid air with a relative humidity cp ,f equal to approximately 50%.
- a relative humidity cp ,f equal to approximately 50%.
- the Ml signature (humid air with non-zero Acp and the presence of analyte A) is located between the M2 signature (humid air with zero Acp and the presence of analyte A) and the M3 signature (humid air with Acp non-zero and absence of the analyte A), clearly showing the effect of the measurement noise associated with the non-zero relative concentration Acp on the signature of the analyte A. It is therefore important to be able to limit or even rule out this measurement noise to improve the quality of analyte A characterization.
- FIG. 3B illustrates examples of the temporal evolution of the concentration cp of the parasitic species P present in the measurement chamber during the initial phase Phi and the characterization phase Ph2, of the measurement signal S m ( t) for the sensitive site 6 m of rank m, and finally of the useful signal Su m (t).
- the left part of the graphs corresponds to the situation in which the concentration cp(t) remains constant between the two fluidic injection phases Phi and Ph2.
- the parasitic species P has a concentration of CPJ value, which results in a measurement signal S m (t) having a reference value Sm ,i.
- the gaseous sample to be analyzed is introduced into the measurement chamber. Due to the presence of the analyte A and since the concentration c p (t) remains constant, the measurement signal S m (t) tends towards a stationary value S m ,f greater than S mi .
- the right part of the graphs corresponds to the situation in which the concentration cp(t) varies between the two fluidic injection phases Phi and Ph2.
- the parasitic species P has a concentration of CPJ value, which results in a measurement signal S m (t) having a value of reference S m ,i.
- the introduction of the gaseous sample leads to this that the concentration cp(t) of the parasitic species P varies, here increases up to a value cp ,f , higher than Acp with respect to the reference value CPJ.
- Patent application FR1913555 filed on November 29, 2019 describes a characterization method comprising such a calibration step.
- the preliminary calibration amounts to determining a correction function expressing the evolution of the reference value S mj of the measurement signal S m (t) associated with the parasitic species P alone (that is to say without the analyte A) as a function of its concentration cp.
- the affinity k P of the parasitic species P with the receptors can be impacted by the presence of the analyte A.
- analyte A adsorbed on the receptors can induce a force of attraction or repulsion of water molecules, modifying the affinity kp accordingly of the parasite species P.
- A is then noted as being the affinity of the parasite species P in the presence of the analyte A.
- the calibration step may then not accurately estimate the measurement noise effective during the Ph2 characterization phase insofar as the interactions of the parasite species P with the receptors are influenced by the presence of the analyte A.
- the characterization method according to the invention is based on the idea of estimating the measurement noise from the interactions of the parasitic species P with the receptors in the presence of the analyte A, and not, as in the prior calibration approach, in the absence of the analyte A.
- the characterization method provides for carrying out, initially, acquisitions of the stationary values Su (n,m)f of the signal useful Su (n,m) (t) for N different gas samples, which contain the same chemical species, namely the same analyte A and the same species or species parasites P, but for which the relative concentration Ac P(n) is different from one acquisition n to another n+1.
- this optimization problem can be solved in two stages: this is then the first embodiment (flowcharts of FIG. 4 and FIG. 5). As a variant, it can be solved in one step: this is the second embodiment (flowchart of FIG. 6). Other methods of solving this optimization problem are of course possible.
- FIG. 4 is a flowchart of a method for characterizing analyte A according to a first embodiment, which makes it possible to improve the quality of the characterization of analyte A by reducing or even eliminating the noise of measurement linked to the non-zero relative Ac P concentration between the Phi and Ph2 injection phases.
- the analyte A is contained in gaseous samples, the latter also comprising at least one parasitic chemical species P.
- the parasitic species P is water molecules, but it may be one or more other parasitic species, such as ethanol and hydrogen sulphide, among others.
- N first signatures (uncorrected signatures) of the gaseous samples are acquired, which are therefore representative of the interactions of the analyte A and of the parasite species P with the receptors .
- an optimization problem is solved so as to estimate the contribution of the parasite species P in the first signatures, in order to then obtain the corrected signatures then characterizing the only analyte A.
- Phase 100 Acquisition of N first signatures, with N>1, of the gaseous samples containing the analyte A and the parasitic species P.
- the following steps 110 to 140 are carried out N times, with N>1, each time for a different gaseous sample, these N gaseous samples containing the analyte A and the parasite species P, and differ from each other at least by the concentration c P of the parasitic species P during the phase Ph2 injection.
- Each acquisition phase is denoted by an indicator n, a nonzero integer, ranging from 1 to N. Note that the larger N, the better the quality of the estimation of the water signature and therefore the correction of the first signatures.
- a carrier gas G (n) is injected into the measurement chamber: this is the fluidic injection phase Phi mentioned above.
- the carrier gas G (n) does not contain the analyte A. It may or may not contain the parasitic species P: the concentration c P(n)i may therefore be non-zero or zero. It may also include other chemical species, but which do not have adsorption/desorption type interactions with the receptors of the 6 m sensitive sites: these are therefore not so-called parasitic species.
- the gaseous sample E (n) is then injected into the measurement chamber: this is the fluidic injection phase Ph2 mentioned above.
- the gaseous sample E (n) of rank n comprises the analyte A in concentration C A(n) and the parasite species P in concentration cp (n)f .
- the gaseous sample may comprise chemical species which do not interact with the receptors. Also, only the analyte A and the parasitic species P have interactions with the receptors and induce a variation of the measurement signal S (n,m) (t).
- step 120 in parallel with step 110, the measurement signals S (n,m) (t) associated with the sensitive sites 6 m are determined, with m ranging from 1 to M, with M >1.
- These measurement signals S (n,m) (t) are therefore representative, during the fluidic injection phase Phi (carrier gas G (n) alone), of the interactions of the parasitic species P, then, during the fluidic injection phase Ph2 (gaseous sample E (n) ), of the interactions of the analyte A and the parasite species P.
- step 130 the reference value S (n,m)i (baseline) associated with the carrier gas during the injection phase Phi is determined, and it is subtracted from the stationary value S (n ,m)f of the measurement signal S (n,m) (t) determined during the injection phase Ph2.
- a signature Su (n,m)f S(n,m)f - S(n,m)i is thus obtained for each sensitive site m, associated with the gaseous sample E (h > for rank acquisition not.
- N first signatures Su (n,m)f for N ranging from 1 to N, and m ranging from 1 to M.
- the corresponding gas samples E (n) and E (n+i) differ between them essentially by the difference Acp (n) 1 Acp (n+i) : we therefore have N differences Ac P of different values from each other.
- the concentration c A of analyte A may or may not vary from one gas sample to another.
- a matrix of first signatures SUA,P representative of the interactions of the analyte A and of the parasitic species P with the receptors of the sensitive sites is formed.
- This matrix is of dimension NxM and is formed of the values Su (n,m)f .
- each row of rank n represents the signature associated with the gaseous sample E (n) , that is to say the M useful measurement values Su (n,m)f of the sensitive sites 6 m .
- a relative concentration vector p formed of the N determined values of the concentration difference Ac P(n) is also formed. This vector is here a vector Nxl dimension column.
- Phase 200 Resolution of an optimization problem so as to obtain N corrected signatures, characterizing the analyte A present in the N gaseous samples.
- c c A is a concentration vector of analyte A, of dimension N ⁇ 1, formed of the N concentration values c A (n) of the gaseous samples
- k A is an affinity vector of the analyte A, of dimension M, formed of the M values of an affinity of interaction of the analyte A with the receptors of the sensitive sites
- A is a vector of affinity of the parasitic chemical species P, of dimension M, formed of the M values of an affinity of interaction of the parasitic chemical species P with the receptors of the sensitive sites in the presence of l analyte A.
- step 220 the following optimization problem is solved:
- a matrix of corrected signatures Suc A (q) is determined for each of the Q local solutions:
- Each of the Q corrected signature matrices Suc A (q) is also normalized to thus obtain Q corrected and normalized signature matrices Sucn A (q) .
- Q corrected and normalized signature matrices Sucn A (q) are also normalized.
- step 222 it is then determined which solution qf, among the Q local solutions, has a minimum variance score.
- a variance score V is calculated for each of the Q matrices Sucn A (q) , and the one which has a minimum score is identified.
- the variance score here is the trace of the covariance matrix for each of the local solutions, ie the sum of the variance of each sensor m for each local solution q. More precisely, the variance score can be, up to a multiplicative factor: where is an N-dimensional unit vector, and where is an M-dimensional vector where each m-value is the average of the normalized corrected signatures for the site sensitive 6 m row m.
- the solution of rank qf, among the Q local solutions then corresponds to the vectors whose product is equal to the matrix of corrected signatures
- the signatures Sucnj ⁇ have been determined which effectively and only characterize the analyte A for the N gaseous samples, despite the presence of the parasitic species P, and without resorting to a prior calibration step.
- the characterization process then provides more precise signatures of analyte A since the measurement noise Ac P kJ >
- FIG. 5 is a flowchart of a method for characterizing analyte A according to a variant of the first embodiment. This variant differs from the method of FIG. 4 essentially by the way of optimizing the cost function g.
- the method comprises a phase 100 of acquisition of N first signatures.
- This phase 100 can be identical or similar to that described with reference to FIG. It can therefore include steps 110 to 150, and is therefore not detailed again here.
- the step 210 of minimizing the cost function f can be identical to that described previously and is not explained again here.
- the step 230 consists in maximizing the cost function g from the Q local solutions obtained following step 210. This amounts here to determining the solution, among the local solutions determined previously, maximizing the function -cost g such that g
- step 231 the matrix of corrected signatures SUC A (c,) is determined for each of the Q local solutions: This step is identical to step 221. However, unlike step 221, the normalization of the Q matrices of corrected signatures is not carried out
- step 232 it is then determined which solution (of rank denoted qf), among the Q local solutions, has a maximum norm, here within the meaning of the Frobenius norm. For it, we calculate the norm for each of the Q local solutions, and we identify the one that presents a maximum standard. As before, the solution of rank qf, among the Q. local solutions, then corresponds to the vectors whose product c is equal to the matrix of corrected signatures Suc ⁇ qf ⁇ [0094] We then normalize the matrix of corrected signatures
- FIG. 6 is a flowchart of a method for characterizing analyte A according to a second embodiment. This method differs from the methods of fig.4 and fig.5 essentially by the way of optimizing the two cost functions f and g.
- the method comprises a phase 100 of acquisition of N first signatures.
- This phase 100 can be identical or similar to that described with reference to FIG. It can therefore include steps 110 to 150, and is therefore not detailed again here.
- ⁇ which has just been determined.
- SVD singular value decomposition
- R Su AP — Ac P kp
- N is greater than M: N > M.
- step 314 it is determined whether a convergence criterion is verified or not. This may involve comparing the variation between i and i+1 of one and/or the other of the variables with a predefined threshold value. When this variation is greater than this threshold, steps 312 and 313 are repeated by incrementing the indicator i by one unit. On the other hand, when this variation is less than or equal to this threshold, we move on to the next step.
- the matrix of corrected signatures Suc A is defined as follows: ⁇ where if is the value of the indicator i when the criterion of convergence is verified.
- the matrix of corrected signatures is defined as being equal to the matrix of first signatures P from which we have subtracted the estimate of the term representative of the measurement noise (impact of the parasitic species).
- the matrix SU ⁇ A can then be normalized to obtain the matrix Sucn A as indicated above at steps 221 and 232. A for the N gaseous samples without resorting to a prior calibration step. The characterization process then provides more accurate Sucn A signatures of analyte A.
- the method according to this second embodiment has the advantage of obtaining the optimal solution in a single step, insofar as the minimization of the objective function f and the maximization of the objective function g are carried out together to obtain the matrix of corrected signatures SU ⁇ A.
- the deviations Acp (n) determined during the N acquisitions of phase 100 can present a more or less significant amplitude of variation, this amplitude of variation being defined as the difference between the maximum deviation max(Acp ( n) ) and the minimum deviation min(Acp (n) ) among).
- this amplitude of variation being defined as the difference between the maximum deviation max(Acp ( n) ) and the minimum deviation min(Acp (n) ) among).
- a low variation amplitude for example of the order of 10%, it is advantageous to use the characterization method according to the second embodiment which then gives more precise results.
- FIG. 7 A illustrates three uncorrected signatures Sui, Su 2 and Su 3 representative of the analyte A in the presence of a parasitic species P of different concentrations.
- the analyte A is butanol and the parasitic species P is water in the vapor phase (humid air).
- the Sui signature (dotted line) corresponds to an Acp ,i deviation of 36.5%
- the Su 2 signature (dashes) corresponds to an ACP ,2 deviation of 33.5%
- the Su 3 signature (solid line) corresponds to an ACP , 2 deviation of 3 by -1%.
- FIG. 7B illustrates two corrected signatures Sui and Suc 2 obtained by correction of the signatures Sui and Su 2 by means of the second phase 300 of the characterization method according to the second embodiment.
- the uncorrected Su 3 signature is reproduced here for comparison (but is not used in the optimization).
- Note that a low Acp deviation has a low impact on the signature Su due to the subtraction of the reference value S m,f .
- It appears that the corrected signatures Suci (dotted lines) and Suc 2 (dashes) are significantly confused and close to the signature Su 3 (solid line), thus illustrating the fact that the impact related to the interactions of the parasite species P with the receivers has been fixed.
- the gaseous samples used during the acquisition phase 100 can comprise several parasitic chemical species: Pi, P2, etc. Also, during step 140, the concentration of these different parasitic species during the injection phases Phi and Ph2, then the deviations AC PI , AC P 2 ... are determined.
- the correction phases 200 and 300 are then similar to those described above, and are based on the optimization of the functions- objective
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Combustion & Propulsion (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020237034318A KR20230155542A (ko) | 2021-03-08 | 2022-03-04 | 적어도 하나의 기생 화학 종을 함유하는 기체 샘플에 존재하는 분석물의 특성화 방법 |
CN202280026206.4A CN117098992A (zh) | 2021-03-08 | 2022-03-04 | 表征含有至少一种寄生化学物质的气体样本中存在的分析物的方法 |
US18/549,403 US20240175853A1 (en) | 2021-03-08 | 2022-03-04 | Method for characterizing an analyte present in a gas sample containing at least one parasitic chemical species |
EP22709746.6A EP4305413A1 (fr) | 2021-03-08 | 2022-03-04 | Procede de caracterisation d'un analyte present dans un echantillon gazeux contenant au moins une espece chimique parasite |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FRFR2102231 | 2021-03-08 | ||
FR2102231A FR3120445B1 (fr) | 2021-03-08 | 2021-03-08 | Procédé de caractérisation d’un analyte présent dans un échantillon gazeux contenant au moins une espèce chimique parasite |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022189292A1 true WO2022189292A1 (fr) | 2022-09-15 |
Family
ID=75850314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2022/055555 WO2022189292A1 (fr) | 2021-03-08 | 2022-03-04 | Procede de caracterisation d'un analyte present dans un echantillon gazeux contenant au moins une espece chimique parasite |
Country Status (6)
Country | Link |
---|---|
US (1) | US20240175853A1 (fr) |
EP (1) | EP4305413A1 (fr) |
KR (1) | KR20230155542A (fr) |
CN (1) | CN117098992A (fr) |
FR (1) | FR3120445B1 (fr) |
WO (1) | WO2022189292A1 (fr) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2011842A1 (fr) | 1968-05-16 | 1970-03-13 | Babcock & Wilcox Co | |
EP3184485A1 (fr) | 2015-12-24 | 2017-06-28 | Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives | Systeme presentant une densite surfacique de dispositifs microelectromecaniques et/ou nanoelectromecaniques augmentee |
WO2018158458A1 (fr) | 2017-03-03 | 2018-09-07 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Procede de calibration d'un nez electronique |
WO2020141281A1 (fr) | 2018-12-31 | 2020-07-09 | Aryballe Technologies | Procede de caracterisation de composes cibles |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1793517C3 (de) | 1968-09-28 | 1974-12-05 | Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt | N(Al),N(B29>Bis-(tert.-butyloxycarbonyl)-insulin und Verfahren zu seiner Herstellung |
-
2021
- 2021-03-08 FR FR2102231A patent/FR3120445B1/fr active Active
-
2022
- 2022-03-04 WO PCT/EP2022/055555 patent/WO2022189292A1/fr active Application Filing
- 2022-03-04 US US18/549,403 patent/US20240175853A1/en active Pending
- 2022-03-04 KR KR1020237034318A patent/KR20230155542A/ko unknown
- 2022-03-04 CN CN202280026206.4A patent/CN117098992A/zh active Pending
- 2022-03-04 EP EP22709746.6A patent/EP4305413A1/fr active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2011842A1 (fr) | 1968-05-16 | 1970-03-13 | Babcock & Wilcox Co | |
EP3184485A1 (fr) | 2015-12-24 | 2017-06-28 | Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives | Systeme presentant une densite surfacique de dispositifs microelectromecaniques et/ou nanoelectromecaniques augmentee |
WO2018158458A1 (fr) | 2017-03-03 | 2018-09-07 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Procede de calibration d'un nez electronique |
WO2020141281A1 (fr) | 2018-12-31 | 2020-07-09 | Aryballe Technologies | Procede de caracterisation de composes cibles |
Non-Patent Citations (4)
Title |
---|
BRENET ET AL.: "Highly-Selective Optoelectronic Nose based on Surface Plasmon Resonance Imaging for Sensing Gas Phase Volatile Organic Compounds", ANAL. CHEM., vol. 90, no. 16, 2018, pages 9879 - 9887, XP002800118, DOI: 10.1021/acs.analchem.8b02036 |
SHAO ET AL.: "Mechanism and Chorocteristics of Humidity Sensing with Polyvinyl Alcohol-Coated Fiber Surface Plasmon Resonance Sensor", SENSORS, vol. 18, 2018, pages 2029 |
SHAO ET AL: "Mechanism and Characteristics of Humidity Sensing with Polyvinyl Alcohol-Coated Fiber Surface Plasmon Resonance Sensor", SENSORS,, vol. 18, 1 January 2018 (2018-01-01), pages 1 - 9, XP002800119, DOI: 10.3390/S18072029 * |
SOPHIE BRENET ET AL: "Highly-Selective Optoelectronic Nose based on Surface Plasmon Resonance Imaging for Sensing Gas Phase Volatile Organic Compounds", ANAL. CHEM,, vol. 90, no. 16, 1 January 2018 (2018-01-01), pages 9879 - 9887, XP002800118, DOI: 10.1021/ACS.ANALCHEM.8B02036 * |
Also Published As
Publication number | Publication date |
---|---|
FR3120445A1 (fr) | 2022-09-09 |
CN117098992A (zh) | 2023-11-21 |
FR3120445B1 (fr) | 2023-02-10 |
EP4305413A1 (fr) | 2024-01-17 |
KR20230155542A (ko) | 2023-11-10 |
US20240175853A1 (en) | 2024-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3906402B1 (fr) | Procede de caracterisation de composes cibles | |
EP3274689B1 (fr) | Procédé et dispositif d'analyse de particules | |
FR3071061B1 (fr) | Systeme de detection perfectionne pour nez electronique et nez electronique comprenant un tel systeme | |
WO2005031324A1 (fr) | Procede et dispositif d’analyse du mouvement dans un milieu diffusant | |
EP4065959B1 (fr) | Procede de caracterisation de composes d'intérêt dans une chambre de mesure présentant une variation d'humidité relative | |
EP4305413A1 (fr) | Procede de caracterisation d'un analyte present dans un echantillon gazeux contenant au moins une espece chimique parasite | |
EP3980751B1 (fr) | Procédé et dispositif d'analyse d'un échantillon, mettant en oeuvre un support résonant | |
WO2021037935A1 (fr) | Méthode et dispositif de caractérisation optique de particules | |
EP3899497A1 (fr) | Dispositif laser pour interferometrie a polarisation | |
EP4085244B1 (fr) | Procede de recalibration d'un nez electronique | |
WO2023187547A1 (fr) | Dispositif et procédé de mesure multivariée d'une présence de composés dans un fluide | |
WO2020201484A1 (fr) | Procede pour configurer un dispositif de spectrometrie | |
FR3100335A1 (fr) | Méthode et dispositif de caractérisation optique de particules | |
WO2023110771A1 (fr) | Procede d'estimation par un nez electronique de l'etat de transformation d'un produit en cours de cuisson | |
FR3134894A1 (fr) | procede de caractérisation d’analytes comportant une variation de température au moyen d’un nez électronique de type interferometrique | |
FR3136555A1 (fr) | Procédé et programme d’ordinateur pour l’étalonnage d’un dispositif électronique de caractérisation d’un fluide, dispositif électronique correspondant | |
EP4337952A1 (fr) | Dispositif et procédé de mesure multisensorielle d'adsorption et désorption de composés d'un fluide | |
FR3139389A1 (fr) | Système interférométrique de caractérisation calibré et présentant un encombrement réduit | |
EP3746765A1 (fr) | Methode de determination d'une vitesse de sedimentation ou de cremage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22709746 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 18549403 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202280026206.4 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 20237034318 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020237034318 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022709746 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2022709746 Country of ref document: EP Effective date: 20231009 |
|
ENP | Entry into the national phase |
Ref document number: 2024502544 Country of ref document: JP Kind code of ref document: A |